OSTX
OS Therapies Inc
+0.13 (+7.43%)1.88USD1.6M成交股數86.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-16下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.1M | 7.4M | 8.8M | 3.8M | 2.5M | 1.3M | 1.2M | 397K | 362K | 1.0M | 455K | 993K |
| 銷售管理費用 | 2.5M | 2.8M | 3.2M | 3.1M | 2.3M | 3.7M | 1.2M | 383K | 268K | 141K | 168K | 522K |
| 營業利益 | −8.6M+77% | −10.2M+103% | −12.0M+392% | −6.9M+782% | −4.8M+668% | −5.0M+332% | −2.4M+292% | −780K-49% | −630K | −1.2M | −622K | −1.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −8.6M+90% | −10.4M+168% | −13.5M+368% | −6.9M+342% | −4.5M+211% | −3.9M+165% | −2.9M+46% | −1.6M-38% | −1.5M | −1.5M | −2.0M | −2.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.20+5% | -0.27+50% | -0.40+122% | -0.21-19% | -0.19-24% | -0.18 | -0.18-53% | -0.26-45% | -0.25 | – | -0.38 | -0.47 |
| 稀釋股數 | 43.9M | 38.7M | 29.3M | 32.0M | 25.1M | 21.2M | 15.9M | 6.0M | 6.0M | – | 5.3M | 5.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 205K | 918K | 270K | 1.9M | 2.8M | 3.0M | 1.9M | 95K | 100K | 39K | 16K | 49K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 9.9M | 7.3M | 6.8M | 9.0M | 10.3M | 4.2M | 2.0M | 1.3M | 1.0M | 798K | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 20.7M | 17.1M | 11.9M | 4.2M | 3.6M | 3.6M | 2.7M | 28.4M | 26.6M | 24.8M | – | – |
| 股東權益 | −11.9M | −10.8M | −6.1M | 3.6M | 4.9M | −4.2M | −707K | −27.1M | −25.5M | −24.0M | −22.5M | −21.3M |
| 負債比 | 209.6% | 233.6% | 173.5% | 47.4% | 34.5% | 85.6% | 135.8% | 2,116.4% | 2,531.7% | 3,109.2% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.6M+33% | – | – | – | −3.4M | – | – | −642K | – | – | – |
| 資本支出 | – | – | – | – | – | 150K | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | −3.6M | – | – | – | – | – | – |
| 折舊攤銷 | – | 125K | – | – | – | 695.00 | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −28.8M | –% | -0.98 | −14.7M |
| FY2024 | – | – | −8.9M | –% | -1.28 | – |
| FY2023 | – | – | −7.8M | –% | -1.46 | – |